Being tested

Trial timeline

Phase 220192024

Trial start year. Dot size reflects participants where reported. Only trials that count towards the status are shown.

relapsing MS · BTK inhibition (B cells and microglia)

Trials are running now and no controlled trial has a readable result yet.

Trials
10
Running now
4
Controlled phase 2/3 trials
4
People in controlled trials
399

Deciding trials (phase 2): 2 met, 0 did not.

Other linked trials: 8

Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.

Trials

Other linked trials: 8

These linked trials do not set the status.

  • Phase 3 · 2025 · Compared with ocrelizumab

  • FENhance 2Ongoing

    Phase 3 · 2021 · Compared with teriflunomide

  • FENhanceOngoing

    Phase 3 · 2021 · Compared with teriflunomide

  • GEMINI 1Missed main goal

    Phase 3 · 2020 · Compared with teriflunomide

  • GEMINI 2Missed main goal

    Phase 3 · 2020 · Compared with teriflunomide

  • Phase 2 · 2025 · Not randomised

The deciding phase and counts come from the Trial Bank’s fixed rules.

Lab evidence

Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.

Loading lab studies…

Loading reviews and guidelines…

History

  • 2026-10-28Trials: 11 → 10
  • 2026-10-27First listed as Being tested

Related hypotheses

Assembled by software from public sources and not checked by people. Each record links to its source. Report an error